The Latest Data for Ruxolitinib Cream in Vitiligo: Finding Context from the Outcomes
Dermatologists Raj Chovatiya, MD, PhD, and David Rosmarin, MD, discuss new research outcomes for the topical JAK inhibitor live from the Revolutionizing Atopic Dermatiti 2023 Annual Meeting in Washington, DC.
United States Raj Chovatiya David Rosmarin Indiana University School Of Medicine Latest Data Ruxolitinib Cream
Source: hcplive.com